Members of the American Society for Clinical Oncology called on legislators Tuesday to build upon the provisions in the 21st Century Cures Act to improve research and treatment.
For three decades, participants in the Modern Healthcare Design Awards have sought to advance the concept of a healing environment. This year, the 30th annual contest saw a coming together of efforts to refine that concept while integrating the sometimes-conflicting principles of value-based design.
What particularly struck Design Awards judge Rulon Stacey about the new Memorial Sloan Kettering Cancer Center in West Harrison, N.Y., was the prominent staircase in the middle of the lobby.
Dr. Joxel Garcia, 53, has been named the inaugural executive director of the University of Texas MD Anderson Cancer Center's prevention and control platform, part of its “Moon Shots Program,” which aims to accelerate and improve cancer survival rates.
New research shows that chances of dying from very early breast cancer are small but the disease is riskier for young women and blacks, the same disparities seen for more advanced cancer.
Dr. Edith Mitchell has been named the new president of the National Medical Association, which represents African-American physicians and has more than 30,000 members.
A project announced Tuesday aims to link drug prices directly to the way drugs improve the health of patients. The project is part of a growing effort to curtail the cost of drugs.
Effective Aug. 3, Kevin Fitzpatrick will become CEO of CancerLinQ, a not-for-profit subsidiary of the American Society of Clinical Oncology.
Some sunbathers are searching for more than a golden glow in a new social media trend that's baffling dermatologists, cancer experts and other clinicians.
Medicaid managed-care provider Centene Corp. is buying insurer Health Net in a $6.8 billion cash and stock deal.
Leading biotech firm Celgene Corp. will pay $1 billion to enter into a 10-year collaboration with Juno Therapeutics. The move broadens the company's cancer drug portfolio by gaining access to Juno's budding pipeline of oncology immunotherapies.
San Francisco-based Dignity Health has tapped Stephen Foerster to serve as chief strategy officer for its Bay Area service area.